Capital Analysts LLC’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6M Buy
501,777
+46,740
+10% +$1.85M 0.48% 46
2026
Q1
$16.2M Buy
455,037
+63,245
+16% +$2.37M 0.43% 54
2025
Q4
$15M Buy
391,792
+31,752
+9% +$1.22M 0.41% 56
2025
Q3
$13.6M Buy
360,040
+76,297
+27% +$2.79M 0.4% 59
2025
Q2
$10M Buy
283,743
+131,174
+86% +$4.3M 0.33% 73
2025
Q1
$4.92M Buy
152,569
+98,019
+180% +$3.29M 0.18% 104
2024
Q4
$1.81M Buy
54,550
+43,983
+416% +$1.48M 0.07% 189
2024
Q3
$351K Buy
10,567
+1,717
+19% +$55K 0.01% 377
2024
Q2
$278K Buy
8,850
+664
+8% +$20.1K 0.01% 408
2024
Q1
$247K Sell
8,186
-1,950
-19% -$56.2K 0.01% 406
2023
Q4
$280K Buy
10,136
+10,111
+40,444% +$262K 0.01% 378
2023
Q3
$1K Buy
+25
New +$642 ﹤0.01% 1147

Other funds holding TCAF

Capital Analysts LLC's TCAF Position: Q2 2026 in Review

Capital Analysts LLC increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 10% in Q2 2026, buying an estimated $1.85M and bringing the position to 501,777 shares worth $20.6M. The position accounts for 0.48% of the portfolio, ranked #46.

Capital Analysts LLC first reported a position in TCAF in Q3 2023 and has held it in 12 quarters since. 358 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • Capital Analysts LLC held 501,777 shares of T. Rowe Price Capital Appreciation Equity ETF worth $20.6M as of Q2 2026.
  • Capital Analysts LLC bought 46,740 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $1.85M.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.48% of Capital Analysts LLC's portfolio in Q2 2026, its #46 holding.
  • Capital Analysts LLC first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q3 2023 and has held it in 12 quarters since.
  • 358 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.